The brokerage has begun coverage with an 'Equalweight' rating and a price target of ₹260 per share, implying an upside potential of 12% from the previous closing price.
Morgan Stanley said Pine Labs is a leader in its key segments, benefiting from a first-mover advantage and a strong partner ecosystem.
The brokerage expects the company to deliver a revenue CAGR of 19% over FY25-FY28E and believes its transition towards an asset-light business model will help drive EBIT margins to 20% by FY28E, compared with 3% in FY25.
The brokerage maintains an 'Equalweight' stance, citing full valuation at 28 times its FY28 EV/EBITDA estimates.
Pine Labs saw two shareholder lock-ins expire this month. The first was on December 8, when 19.8 million shares, or 2% of the outstanding equity, became eligible for trading. The second occurred on December 12, when 39.7 million shares, or 3% of the total outstanding equity, were freed up for trade.
In its first quarterly result after listing, Pine Labs' GTV grew by 92% from last year to $48.2 billion, while the number of transactions grew by 44% from last year to 1.9 billion.
Its net profit stood at ₹6 crore from ₹5 crore in the previous quarter, while its Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) on an adjusted basis also remained flat at ₹122 crore from ₹121 crore last year.
There was also a sharp drop in ESOP expenses that contributed to the profitability of the company this quarter. ESOP expenses fell 28% from last year and stood at 4% of revenue, compared to 7% last year.
The stock of Pine Labs made a decent market debut on November 14, listing at ₹242 apiece on the bourses. This marked a premium of 9.5% over the IPO price.
Shares of Pine Labs settled 4.16% lower on Monday at ₹232.84. The stock trades just 5% above its IPO price of ₹221.
/images/ppid_59c68470-image-176646009135172468.webp)


/images/ppid_59c68470-image-17664576042728924.webp)
/images/ppid_59c68470-image-176645764403426643.webp)
/images/ppid_59c68470-image-176645756747548553.webp)
/images/ppid_59c68470-image-176645752912176993.webp)
/images/ppid_59c68470-image-176645753291518500.webp)
/images/ppid_a911dc6a-image-176645564219963220.webp)

/images/ppid_59c68470-image-176645505804129847.webp)
/images/ppid_59c68470-image-176645509111412944.webp)